Zydus Lifesciences gets final approval from USFDA for Azithromycin tablets
Zydus Lifesciences Ltd announced that it has received final approval from the US Food and Drug Administration to manufacture and market its generic version of Azithromycin tablets, which are used to treat certain bacterial infections. The US Food and Drug Administration (USFDA) approved Zydus Lifesciences’ manufacturing and marketing of Azithromycin tablets 500 mg strength, according to